Kimberly Clark Corp (KMB) · Nov 2, 2026 · Acquisition
$3.50 cash + shares — $3.50 cash and 0.14625 KMB shares per Kenvue share
Kimberly-Clark completed its Kenvue acquisition, creating a roughly $31.6 billion combined sales platform—but integration and debt execution now begin.
Kimberly-Clark is transforming from a household-products company into a broader global health and wellness platform by combining its personal-care brands with Kenvue’s consumer-health portfolio. The closing was largely anticipated: the deal was announced in 2025, approved by shareholders in January 2026, and expected to close in the second half or fourth quarter of 2026.
The strategic transition is now real, not proposed. Kimberly-Clark says the acquisition is complete and that the combined company will include 10 billion-dollar brands. This gives the company a much larger health-and-wellness footprint across everyday care categories, with estimated fiscal 2025 sales organized into four regions.
| Combined business footprint | FY2025 sales |
|---|---|
| North America (Combined financial information) | $18.0B |
| Asia Pacific Focus Markets (Combined financial information) | $4.3B |
| EMEA (Combined financial information) | $5.0B |
| Enterprise Markets (Combined financial information) | $4.3B |
| Approximate combined total | $31.6B |
This is an execution milestone, not proof that the deal is working financially. The filing establishes ownership and the new operating footprint, but it does not report realized synergies, combined earnings, or post-close cash flow. The company’s own combined figures are explicitly estimates and are not prepared as formal pro forma financial statements, limiting what can yet be concluded about the economics of the enlarged business. 〔0〕
The main new burden is integration and leverage. Kenvue shareholders receive $3.50 in cash and 0.14625 Kimberly-Clark shares for each Kenvue share, while Kenvue’s stock stopped trading on November 2, 2026. The filing also acknowledges substantially higher indebtedness, integration costs, possible disruption, and the risk that projected synergies may not arrive on schedule. Those risks were already part of the deal thesis; closing removes transaction uncertainty but transfers the test to operational delivery.
Bottom line: The acquisition materially advances Kimberly-Clark’s strategic repositioning, but the closing itself was largely expected and brings no evidence yet that the promised benefits have been realized. The story has moved from deal approval to integration execution, making this an important but only mildly positive update relative to expectations.
First combined quarterly results
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!